Page 14 - Shankar Musunuri News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Shankar musunuri. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Shankar Musunuri Today - Breaking & Trending Today

Ocugen to Present at BIO International Convention 2023

MALVERN, Pa., May 23, 2023 Ocugen, Inc. , a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today announced. | May 23, 2023 ....

United States , Shankar Musunuri , Quan Vu , Boston Convention , International Convention , Exchange Commission , Exhibition Center , Ocugen Inc , Chief Executive Officer , Chief Financial Officer , Chief Business , Private Securities Litigation Reform Act , Nc Stock Exchange , Press Release , Oday Ocgn Us67577c1053 ,

Ocugen Provides Business Update with First Quarter 2023 Financial Results

Conference Call and Webcast Today at 8:30 a.m. ET Announced Positive Preliminary Safety and Efficacy Results from the Phase 1/2 Trial of OCU400 for the Treatment of Retinitis Pigmentosa and Leber. | May 5, 2023 ....

United States , Shankar Musunuri , Ocugen Inc , Exchange Commission , Head Of Communications , Conference Call , Webcast Today , Positive Preliminary Safety , Efficacy Results , Retinitis Pigmentosa , Leber Congenital Amaurosis , Orphan Drug Designation , Associated Retinopathies Including Stargardt , Cone Rod Dystrophy , Multiple Proposals , Federal Funding , Inhaled Vaccines , Chief Executive Officer , Investigational New Drug , North America , Private Securities Litigation Reform Act , Nc Stock Exchange , Press Release , Nd Ocgn Us67577c1053 ,

Ocugen (OCGN) Q1 2023 Earnings Call Transcript

OCGN earnings call for the period ending March 31, 2023. ....

United States , Jennifer Kim Cantor Fitzgerald , Quan Vu , Shankar Musunuri , Swayampakula Ramakanth , Jonathan Aschoff , Robert Leboyer , Daniil Gataulin , Jennifer Kim , Daniil Gataulin Chardan , Swayampakula Hc Wainwright , Sharon Choe , Shankar Musunuri Co , Drug Administration , Company Analyst , Cantor Fitzgerald , Private Securities Litigation Reform Act , Motley Fool Stock Advisor , Stock Advisor , Chief Executive , Cone Rod Dystrophy , Financial Officer , Chief Business , Noble Capital , Capital Markets ,

Ocugen Announces OCU410ST Receives Orphan Drug Designation for Treatment of ABCA4-Associated Retinopathies

U.S. Food & Drug Administration grants orphan drug designation to OCU410ST for the treatment of ABCA4-associated retinopathies including Stargardt, RP19 and CORD3MALVERN, Pa., April 27, 2023 . | April 27, 2023 ....

United States , Shankar Musunuri , Us Food Drug Administration , Exchange Commission , Ocugen Inc , Nuclear Hormone Receptors Nhrs , Drug Administration , Orphan Drug Designation , Retinitis Pigmentosa , Orphan Receptor , Nuclear Hormone Receptors , Private Securities Litigation Reform Act , Nc Stock Exchange , Press Release , 023 Ocgn Us67577c1053 ,

Ocugen (OCGN) Receives Orphan Drug Designation for OCU410ST

Ocugen (OCGN) Receives Orphan Drug Designation for OCU410ST
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Shankar Musunuri , Head Of Communications , Nuclear Hormone Receptors Nhrs , Ocugen Inc , Exchange Commission , Wall Street , Orphan Drug Designation , Retinitis Pigmentosa , Orphan Receptor , Nuclear Hormone Receptors , Private Securities Litigation Reform Act ,